Ivo Staijen
Head-Equity Investments presso HBM Partners AG (Investment Management)
Profilo
Dr. Ivo Staijen is a Head Public Equity & Portfolio Manager at HBM Partners AG.
He has over 15 years of experience in the pharma industry and investment analysis and portfolio management.
He was previously a Senior Biotechnology Analyst at Bank Sarasin and Department Head at MDS Pharma Services.
He holds a Ph.D.
in biotechnology from ETH Zurich and an M.Sc.
in chemistry from the University of Groningen.
Posizioni attive di Ivo Staijen
Società | Posizione | Inizio |
---|---|---|
HBM Partners AG (Investment Management)
HBM Partners AG (Investment Management) Investment ManagersFinance HBM Partners AG (Investment Management) (HBM-IM) is the asset management division of HBM Partners AG. The firm is headquartered in Zug and was founded in 2001. HBM-IM provides investment advisory services to private companies. They manage the fund HBM Healthcare Investments. | Head-Equity Investments | 01/04/2003 |
Precedenti posizioni note di Ivo Staijen
Società | Posizione | Fine |
---|---|---|
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 03/10/2012 |
Bank Sarasin & Cie AG (Broker) | Analyst-Equity | 06/02/2003 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Health Technology |
Bank Sarasin & Cie AG (Broker) | Finance |
HBM Partners AG (Investment Management)
HBM Partners AG (Investment Management) Investment ManagersFinance HBM Partners AG (Investment Management) (HBM-IM) is the asset management division of HBM Partners AG. The firm is headquartered in Zug and was founded in 2001. HBM-IM provides investment advisory services to private companies. They manage the fund HBM Healthcare Investments. | Finance |
- Borsa valori
- Insiders
- Ivo Staijen